Table 1.
Chlamydia infection status of patients used in this study
| Age (years)/ | Proliferative responses (SI) of PBMC to | Titres of antibodies to | |||
|---|---|---|---|---|---|
| Patient ID | sex | Ct EB | Ct hsp60 | Cpn | Ct |
| WD | 77 M | 1·02 | 5·6 | – | – |
| 484 | 88 M | ND | ND | ND | ND |
| SZ | 75 M | 2·2 | 7 | 128 | – |
| TR | 64 M | 6·6 | 3·2 | – | – |
| MI | 78 M | 1·2 | 0·75 | 512 | – |
| HP | 55 M | 6·8 | 2 | 128 | – |
| 7464 | 73 M | 3·2 | 6·4 | 128 | – |
| PN | 76 F | 1·5 | 6·9 | ND | ND |
| RK | 76 M | 2·9 | 2·5 | 512 | – |
| FR | 64 F | 79 | 56 | 32 | 32 |
| 195 | 67 M | 3·3 | 2 | 512 | – |
| TR | 71 M | 3·6 | 2·1 | 128 | – |
| ST | 79 M | 27·5 | 2·8 | ND | ND |
| 5868 | 74 M | 1·5 | 2·5 | – | – |
Peripheral blood mononuclear cell (PBMC) proliferative responses to Chlamydia trachomatis (Ct) elementary bodies (EB) and Ct hsp60. Serum antibody titres to Chlamydia pneumoniae (Cpn) and Ct, as determined by micro-immunofluorescence assay (MIF). Results are represented as reciprocal titres with a titre < 1/32 being negative (–). ND, Patients not tested; SI, stimulation index.